New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
12:13 EDTELOSSyneron Medical recommend following FDA clearance at Maxim
Maxim recommends investors continue buying shares of Syneron Medical following the FDA clearance of UltraShape. Maxim says UltraShape expands the base of body shaping treatments that physicians may use with complimentary Syneron systems and it keeps a Buy rating on the stock with a $16 price target.
News For ELOS From The Last 14 Days
Check below for free stories on ELOS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2014
09:03 EDTELOSSyneron Medical's Picoway skin device granted CE Mark
Subscribe for More Information
July 21, 2014
09:04 EDTELOSSyneron Medical receives clearance from CFDA for its elure lotion
Syneron Medical announced that it has received the China Food and Drug Administration, or CFDA, clearance for its elure Advanced Skin Brightening Lotion. The elure skin brightening solution is a new cosmetic product originally available only from dermatologists, plastic surgeons and other medical aesthetic providers.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use